Value of butylphthalide injection combined with edaravone in the treatment of acute cerebral infarction
丁苯酞注射液联合依达拉奉治疗急性脑梗死的价值

摘要

目的 在急性脑梗死病患治疗中联用丁苯酞注射液及依达拉奉施治的干预意义。方法 试验者是2020.04至2022.04在医院治疗的急性脑梗死病患例数共计80例，采取随机数字表法分组，一组设为对照组，病例数为40例，采用常规疗法，另一组设为观察组，组间病患数量为40例，联用丁苯酞注射液及依达拉奉，比对组间总疗效、神经功能及日常生活能力各项治疗效果差异。结果 对照组病患施治后总有效率比对照组病患高，P＜0.05；观察组病患施治后神经功能评分比对照组病患低，观察组病患日常生活能力评分比对照组病患高，P＜0.05。结论 以丁苯酞注射液及依达拉奉联用施治，可对病患症状进行有效缓解，同时还能起到改善病患神经功能及增强其自理能力，适宜临床应用。

Abstract

Objective To investigate the intervention significance of butylphthalide injection combined with edaravone in the treatment of patients with acute cerebral infarction.
Methods the subjects were 80 patients with acute cerebral infarction who were treated in the hospital from April 2020 to April 2022. They were divided into groups by random number table method. One group was set as the control group, with 40 cases, using conventional therapy, and the other group was set as the observation group, with 40 patients between the groups. Butylphthalide injection and edaravone were used to compare the differences in the total efficacy, neurological function and ADL between the groups.
Results the total effective rate in the control group was higher than that in the control group (P＜0.05; The score of neurological function in the observation group was lower than that in the control group, and the score of ADL in the observation group was higher than that in the control group (P<0.05).
Conclusion   the combination of butylphthalide injection and edaravone can effectively alleviate the symptoms of patients, improve the neurological function of patients and enhance their self-care ability, which is suitable for clinical application.